A new TRβ mutation in resistance to thyroid hormone syndrome

Thyroid hormones (TH) exert their actions by binding nuclear receptors alpha (TRα1) and beta (TRβ1 and TRβ2). Resistance to thyroid hormone (RTH) is a clinical syndrome with various clinical manifestations, its hallmark being decreased tissue sensitivity to the action of thyroid hormones. We report...

Full description

Saved in:
Bibliographic Details
Published inHormones (Athens, Greece) Vol. 15; no. 4; pp. 534 - 539
Main Authors Neamţu, Corina, Ţupea, Claudiu, Păun, Diana, Hoisescu, Anca, Ghemigian, Adina, Refetoff, Samuel, Sriphrapradang, Chutintorn
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Thyroid hormones (TH) exert their actions by binding nuclear receptors alpha (TRα1) and beta (TRβ1 and TRβ2). Resistance to thyroid hormone (RTH) is a clinical syndrome with various clinical manifestations, its hallmark being decreased tissue sensitivity to the action of thyroid hormones. We report the case of a family harbouring a novel TRβ mutation. Sequencing of the TRβ gene revealed a single nucleotide substitution-C to G in codon 340: glutamine was replaced by glutamic acid. The clinical picture and biochemical and hormonal panel showed significant differences within the family, despite their sharing the same mutation. We also present the result of low-dose antithyroid treatment in one member of the family diagnosed with this rare condition.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1109-3099
2520-8721
DOI:10.14310/horm.2002.1700